Last quarter (Q4 2023), Enfusion's total revenue was $46.49M, an increase of 14.73% from the same quarter last year. In Q4, Enfusion's net income was $623.00K. See Enfusion’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 168.45M	$ 174.53M	$ 150.35M	$ 111.70M	$ 79.56M	$ 59.03M
Cost of Revenue	$ 425.00K	$ 425.00K	$ -47.10M	$ -31.84M	$ 21.36M	$ 16.96M
Gross Profit	$ 174.11M	$ 174.11M	$ 103.25M	$ 79.86M	$ 58.21M	$ 42.07M
Operating Expense	$ 104.95M	$ 104.95M	$ -115.21M	$ -355.74M	$ 52.13M	$ 28.20M
Operating Income	$ 11.95M	$ 11.95M	$ -11.96M	$ -275.88M	$ 6.07M	$ 13.87M
Net Non Operating Interest Income Expense	$ 1.64M	$ 1.64M	$ 413.00K	$ -4.59M	$ -1.66M	$ -724.00K
Other Income Expense	$ 2.10M	$ 2.10M	$ 638.00K	$ 1.19M	$ 82.00K	$ -3.00K
Pretax Income	$ 11.48M	$ 11.48M	$ -12.19M	$ -281.66M	$ 4.49M	$ 13.14M
Tax Provision	$ 2.23M	$ 2.23M	$ 1.07M	$ 579.00K	$ 433.00K	$ 486.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 15.90M	$ 6.03M	$ -7.65M	$ -158.32M	$ 4.06M	$ 12.66M
Basic EPS	$ 0.06	$ 0.07	$ -0.10	$ -2.26	$ 0.06	$ 0.20
Diluted EPS	$ 0.06	$ 0.07	$ -0.10	$ -2.26	$ 0.06	$ 0.20
Basic Average Shares	$ 352.81M	$ 88.20M	$ 85.39M	$ 83.05M	$ 64.07M	$ 64.07M
Diluted Average Shares	$ 517.72M	$ 129.43M	$ 85.39M	$ 83.05M	$ 64.07M	$ 64.07M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 105.37M	$ 105.37M	$ -162.31M	$ -387.58M	$ 73.49M	$ 45.16M
Net Income From Continuing And Discontinued Operation	$ 6.03M	$ 6.03M	$ -7.65M	$ -158.32M	$ 4.06M	$ 12.66M
Normalized Income	$ 12.65M	$ 15.47M	-	-	$ 4.06M	$ 12.66M
Interest Expense	-	-	-	-	$ 1.66M	$ 724.00K
EBIT	$ 11.48M	$ 11.48M	$ -12.19M	$ -277.07M	$ 6.16M	$ 13.87M
EBITDA	$ 13.26M	$ 21.56M	$ -5.82M	$ -279.47M	$ 8.45M	$ 15.02M

Currency in USD

Enfusion Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing